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from which a solvent systems A comprising methanol:ammonia in the ratio of 100:1.5 (v/v) and
B comprising chloroform:methanol in the ratio of 90:10 (v/v) were found to be most suitable as
it showed a high degree of separation of different components of these preparations. It was also
found that iodine fuming technique is the best visualizing method for examining the TLC chro-
matograms of these drug samples prior to subsequent instrumental analysis.
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Any substance (natural, semi-synthetic or synthetic) that mod-
iﬁes physiological system or pathological states for the beneﬁts
of the recipient is called drug.1 Drugs play an important role in
individual’s life and are used by different individuals for differ-
ent purposes. Some use them for sustaining and prolonging
life; to others, drugs provide escape from the pressure of life.
Drugs are used for curing and ﬁghting diseases. Individuals
use drugs with or without the prescription given by doctor.
Individuals may purchase the drugs either legally or illegally.2Those drugs which can be purchased without the prescrip-
tion of doctor are known as over the counter (OTC) drugs.3
These drugs are covered under the consumer healthcare seg-
ment of pharmaceutical companies and can be considered as
non-prescription drugs.4 There are an estimated 350,000
OTC drugs which can be purchased from pharmacies, grocery
stores and convenience stores etc without any prescription.
They include analgesics, cold and cough medications, antacids,
antihistamines, sedatives etc. Cough syrups, sleeping aids and
appetite-depressants are commonly abused. Because of their
easy availability, they can be utilized to relieve variety of daily
health problems.3 To reduce or nullify the symptoms of illness
or to treat the negative reactions, doctor prescribes the medi-
cines. But self medication of OTC at a time or combination
of OTC drugs and prescription drugs can be harmful and have
high abuse potential. For examples, some OTC drugs, whenEgypt J
2 M.K. Chahal et al.taken with alcohol cause drowsiness, dizziness, euphoria, ner-
vousness, blurred vision, ringing in ears etc. At a higher dose
these effects are intensiﬁed along with other symptoms such
as confusion, muscle twitching, irregular heartbeat, tremors,
convulsions etc. They may impair the ability to safely drive a
vehicle because they can cause drowsiness or excitability.5
Cases may include accidents due to the misuse of drugs or
deliberate overdose or they could contribute to vehicle acci-
dents etc.6 The increase in the abuse of OTC drugs has been
facilitated by ineffective control over their licit supply. The
abuse of these drugs is a serious and growing public health
problem all over the world. Large doses of OTC drugs can
be harmful.3 When taken in excess amount dependency can
be developed.2 Abuse of OTC drugs causes physiological
dependency, psychologically dependency or both.7
Cough–cold preparations are one of the major areas of
OTC drugs.8 A cough medicine, syrup or linctus is a pharma-
ceutical preparation used to treat cough and related condi-
tions. Cough–cold preparations are a typical example of the
over the counter drugs that have been heavily abuse due to
their easy availability, cost effectiveness and inducing feeling
desired by the abusers.1 Cough–cold preparations consist of
antihistamines (e.g. chlorpheniramine), antitussives (e.g.
codeine, dextromethorphan), decongestants (e.g. phenyle-
phrine), expectorants (e.g. guaifenesin) and sleep aids. Antihis-
tamine acts on histamine receptor and reduces itchy eyes,
sneezing, runny nose, itchy nose and throat. Antitussives act
on central nervous system to raise the threshold of cough cen-
ter. Decongestants reduce the production of mucus and swel-
ling in the mucus membrane by constricting the blood vessels
in the nose. Expectorants increase the bronchial secretion or
reduce its viscosity, facilitating its removal by coughing
through salt mechanism. Sleep aids interfere with the chemical
activity in the brain and nervous system by limiting communi-
cation between the nerve cells. This reduction in brain activity
allows a person to fall asleep more easily.1,7 Around 1 million
(1.7%) and 3.1 million (5.3%) persons, aged between 12 and
25 years, had misused an OTC cough and cold medication to
get high in 2005 and 2006.9 Cases had been reported in which
death occurred due to toxic effects induced by ingestion of
high amounts of cough–cold preparations.10–15 Authors also
reported cases in which a number of deaths occurred due to
the ingestion of cough syrups containing dextromethorphan.16
Detection and quantiﬁcation of active components in OTC
preparations using thin layer chromatography and high per-
formance thin layer chromatography has been reported.17–19
Sagathiya et al.20 used reverse phase high performance liquid
chromatography and high performance thin layer chromato-
graphic methods for the determination of dextromethorphan
hydrobromide and guaifenesin in pharmaceutical cough–cold
preparation. Darwish et al.21 quantitatively determine chlor-
pheniramine maleate and dexamethasone in oral liquids by
high performance liquid chromatography and high perfor-
mance thin layer chromatography. Mabrouk et al.22 deter-
mined loratadine and pseudoephedrine sulfate in
pharmaceutical formulation by reverse phase liquid chro-
matography with derivative spectrophotometry. Galli et al.23
developed a high performance liquid chromatographic method
for analysis of a cough syrup containing dextromethorphan,
guaifenesin, benzoic acid, saccharin and other components
such as citric acid and straw berry ﬂavor. Lin et al.24 analyzed
dextromethorphan and its three metabolites (dextrorphan,Please cite this article in press as: Chahal MK et al. Thin layer chromatographic anal
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plasma using high performance liquid chromatography with
ﬂuorometric detector. Louhaichi et al.25 determine pseu-
doephedrine, pheniramine, guaifenesin, pyrilamine, chlor-
pheniramine and dextromethorphan in cough and cold
pharmaceuticals by high performance liquid chromatography.
In 2011, authors analyzed and quantiﬁed both active
(dextromethorphan, guaifenesin) and inactive (benzoic acid,
saccharin) ingredients in some cough syrups by high perfor-
mance liquid chromatography.26 Mahesh et al.27 developed
reverse phase high performance liquid chromatographic
method for the determination of acetaminophen, caffeine,
phenylephrine hydrochloride, and dextromethorphan hydro-
bromide in some OTC tablet formulations. Chakraborthy
et al.28 estimated paracetamol, cetirizine and dextromethor-
phan using reverse phase high performance liquid chromatog-
raphy. In 2003, authors determined dextromethorphan and
dextrorphan in human urine by gas chromatography ﬂame
ionization detection method without any derivatization step.29
In 2013, determination of chlorpheniramine maleate and
phenylpropanolamine in some cough syrups by ultraviolet
spectrophotometry had been reported.30 Deshmukh et al.31
used the ﬁrst order derivative ultraviolet spectrophotometry
for the simultaneous estimation of levocetirizine hydrochloride
and phenylephrine hydrochloride in bulk and combined
dosage form. Mallah et al.32 quantiﬁed paracetamol content
in solid OTC pharmaceutical preparations using Fourier trans-
form infrared spectroscopy. Some authors utilized spectroﬂuo-
rimetric methods for the determination of phenylephrine in
excess of paracetamol and for analysis of mixtures of guaifen-
esin and phenylephrine hydrochloride in some OTC prepara-
tions.33,34 Identiﬁcation of active components and their
metabolites in toxicological samples using gas chromatogra-
phy–mass spectrometry, liquid chromatography–tandem mass
spectrometry and ultra-performance liquid chromatography–
tandem mass spectrometry has been also reported.35–37
Most of the work had been done on the pharmaceutical
preparations of solid form such as powder or tablets. So, in
the present study an attempt has been made to analyze some
common OTC cough–cold preparations by thin layer chro-
matography. Both powder and syrup samples are analyzed
simultaneously using thin layer chromatography.
2. Materials and methods
2.1. Collection of samples
2.1.1. Standard samples
Standard samples of dextromethorphan hydrobromide
(DXM), phenylephrine hydrochloride (PHED), paracetamol
(PCM) and chlorpheniramine maleate (CHPH) were procured
from IITR (Lucknow). Details regarding their color, composi-
tion and location of collection of samples studied are given in
Table 1.
2.1.2. Pharmaceutical preparations
All drug samples were purchased in the form of pharmaceuti-
cal preparations from the local market. Descriptions of the
samples regarding their color, composition and respective
manufacturers of samples studied are given in Table 1. These
samples were purchased from medical shops in the Patialaysis of some common over the counter (OTC) cough–cold preparations, Egypt J
Table 1 Description of various drug samples analyzed in the present study.
S. No. Sample name Code Form Color Composition Manufacturer Location
1. Dextromethorphan
hydrobromide
S1 Powder White Dextromethorphan hydrobromide Sigma–Aldrich, Bangalore Lucknow
2. Chlorpheniramine maleate S2 Powder White Chlorpheniramine maleate Sigma–Aldrich, Bangalore Lucknow
3. Phenylephrine S3 Powder White Phenylephrine Sigma–Aldrich, Bangalore Lucknow
4. Paracetamol S4 Powder White Paracetamol Sigma–Aldrich, Bangalore Lucknow
5. Flucold FCD Tablet Light
orange
Chlorpheniramine maleate-2 mg Glaxo Smith Kline Pharmaceutical, Bangalore Patiala
Paracetamol-325 mg
Phenylephrine hydrochloride10 mg





7. Febrex plus FRX Tablet Yellow Chlorpheniramine maleate-2 mg Indoco Remedies, Baddi, H.P. Ludhiana
Paracetamol-500 mg
Phenylephrine hydrochloride-10 mg
8. Snezrest SZT Tablet Light pink Caﬀeine anhydrous-30 mg Psychotropics India, Haridwar Patiala
Paracetamol-600 mg
Phenylephrine hydrochloride-10 mg




10. Cold-Go COL Tablet Yellow Chlorpheniramine maleate-2 mg Torque Pharmaceutical, Jharmajri Patiala





Tablet Light pink Chlorpheniramine maleate-2 mg Glaxo Smith Kline Pharmaceutical, Bangalore Patiala
Paracetamol-500 mg
Phenylephrine hydrochloride-15 mg
12. Chericof CHF Liquid Pink Chlorpheniramine maleate-2 mg Solrex Pharmaceuticals, Baddi, H.P. Patiala
Dextromethorphan hydrobromide-10 mg
Phenylephrine hydrochloride-5 mg
13. Piriton-CS PTNCS Liquid Pink Chlorpheniramine maleate-4 mg Glaxo Smith Kline Pharmaceutical, Bangalore Patiala
Dextromethorphan hydrobromide-10 mg
14. Piriton PTN Liquid Light
orange
Ammonium chloride-125 mg Glaxo Smith Kline Pharmaceutical, Bangalore Patiala
Chlorpheniramine maleate-2.5 mg
Sodium citrate-55 mg

































































































































Solutions of standard sample were prepared by dissolving
0.5 mg of each sample in 2 ml mixture of chloroform and
methanol (1:1 v/v). The test tube was kept for a few minutes
and contents were then ﬁltered through Whatman ﬁlter paper
no. 1. The ﬁltrate was collected and centrifuged. The super-
natant was transferred to another clean test tube for TLC
analysis.
2.2.2. Pharmaceutical preparations
 For tablets: 2 tablets of each preparation were crushed and
homogenized with the help of pestle and mortar. 0.5 mg of
each crushed tablet was dissolved in 2 ml mixture of chloro-
form and methanol (1:1 v/v) in a test tube and kept for a
few minutes. The contents were then ﬁltered through What-
man ﬁlter paper no. 1. The ﬁltrate was collected and cen-
trifuged. The supernatant was transferred to another clean
test tube for TLC analysis.
 For syrups: 0.5 ml of syrup was dissolved in 2 ml mixture of
chloroform and methanol (1:1 v/v) and kept for a few min-
utes. Contents were then ﬁltered through Whatman ﬁlter
paper no. 1. Filtrate was collected and centrifuged. The
supernatant was transferred to another clean test tube for
TLC analysis.Table 2 List of various chemicals used in the present study.
S. No. Chemicals Manu





6 Carbon tetrachloride Merc
7 Chloroform Merc
8 Cyclohexane Loba
9 Diethyl ether Merc





15 Ethyl acetate Merc
16 Formaldehyde Loba
17 N-hexane Loba
18 Isopropyl alcohol Merc
19 Isobutyl alcohol Merc
20 Liquid paraﬃn Merc
21 Methanol Loba
22 Methylene chloride Loba
23 Petroleum ether Merc
24 Toluene Merc
25 Xylene S.D.
26 Silica gel-G Merc
27 Sulfuric acid Loba
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Various chemicals were used during the thin layer chromato-
graphic analysis of OTC cough–cold preparations. The details
of the chemicals used with their respective manufacturers have
been given in Table 2.
2.4. Thin layer chromatography
Twenty solvent systems (mobile phase) were tried on each of
drug sample (standard as well as pharmaceutical preparation)
to ﬁnd out the most suitable solvent system that could be
applied universally for the thin layer chromatographic separa-
tion of all OTC cough–cold preparations. The twenty solvent
systems used in the present study have been given in Table 3.
Thin layer chromatographic plates (20  20 cm) were pre-
pared manually. A mechanical applicator was used to make
a uniform layer of silica gel G on supporting medium. Before
spotting, TLC plates were activated for half an hour at 110 C
in an oven. An aliquot amount of samples were then applied
manually using a ﬁne capillary tube. The samples were applied
2 cm above the base of plate. The spots were allowed to air dry
at room temperature for 1 min. A solvent chamber was satu-
rated using various solvent systems. The spotted TLC plates
were placed in saturated solvent chamber at an angle of 45
and the chamber was covered with a lid. The solvent front
was allowed to migrate to a distance of 10 cm above the origin.
Developed plates were taken out and dried at room tempera-
ture after the completion of run. The separated spots offacturers
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Table 3 List of various solvent systems tried for TLC analysis of selected OTC cough–cold preparations.
S. No. Solvent system codes Solvent systems Ratio
1 A Methanol:ammonia 100:1.5
2 B Chloroform:methanol 90:10
3 C Ethyl acetate:methanol:ammonia 85:10:5
4 D Isopropyl alcohol:chloroform:ammonia 45:45:10
5 E Chloroform:acetone 80:20
6 F Xylene:n-hexane:diethylamine 50:25:10
7 G Benzene:ethanol 60:40
8 H Cyclohexane:acetone:chloroform 60:30:20
9 I Dichloroethane:methanol:water 95:5:0.2
10 J Methylene chloride:ether:methanol:water 77:15:8:1.2
11 K Cyclohexane:toluene 50:50
12 L Acetone:methanol 60:40
13 M Cyclohexane:2-propanol:diethylamine 50:40:10
14 N n-Hexane:dioxane:methanol 70:20:10
15 O Acetone:n-hexane 85:15
16 P Isobutyl alcohol:acetic acid:water 100:10:2
17 Q n-Hexane:toluene:acetic acid 50:50:2
18 R Petroleum ether:diethyl ether 80:20
19 S Petroleum ether:liquid paraﬃn 90:10
20 T Cyclohexane:toluene:diethyl ether 80:10:10
Thin layer chromatographic analysis of cough–cold preparations 5samples were visualized in strong day light, under short and
long ultraviolet radiations and with iodine fuming method,
and their respective hRf values were calculated using the fol-
lowing equation:
hRf ¼ ðDistance traveled by solute from origin=
Distance traveled by solvent from originÞ  1003. Results and discussion
In the present study, eleven samples of OTC cough–cold
preparations including tablets and syrups along with four stan-
dard samples of active ingredient were analyzed using thin
layer chromatography. Twenty solvent systems were tried
out for the separation of various components of selected phar-
maceutical preparations. Developed thin layer chromato-
graphic plates were examined in strong day light, under
short and long ultraviolet radiations and with iodine fuming
method. The results obtained in terms of number of spots
and their respective hRf values were calculated and were found
to be different with different mobile phases.
3.1. For tablets
Solvent systems E, H, J and T failed to separate any compo-
nent of the selected pharmaceutical preparations. Solvent sys-
tems L, N and R gave less number of spots for different tablet
formulations.
With solvent system A, no spot was observed under strong
day light and under UV light. But with iodine fumes (Fig. 1
and Table 4), one spot at hRf 85 for sample 1, one spot at
hRf 30 for sample 2, one spot at hRf 66 for sample 4, two spots
at hRf 32 and 65 for sample 5, one spot at hRf 67 for sample 6,
two spots at hRf 65 and 85 for sample 7, two spots at hRf 35
and 67 for sample 8, one spot at hRf 67 for sample 9, two spots
at hRf 35 and 67 for sample 10 and two spots at hRf 33 and 67Please cite this article in press as: Chahal MK et al. Thin layer chromatographic anal
Forensic Sci (2016), http://dx.doi.org/10.1016/j.ejfs.2016.04.006for sample 11 were observed. All separated spots produced
brown color after reacting with iodine fumes. Iodine fuming
method failed to produce any spot for sample 3.
With solvent system C, no spot was observed under strong
day light and under UV light. But with iodine fumes, one spot
at hRf 98 for sample 1, one spot at hRf 38 for sample 2, one
spot at hRf 38 for sample 5, one spot at hRf 39 for sample
6, two spots at hRf 38 and 98 for sample 7, one spot at hRf
38 for sample 8, one spot at hRf 38 for sample 9, one spot
at hRf 37 for sample 10 and one spot at hRf 36 for sample
11 were observed (Table 4). All separated spots produced
brown color after reacting with iodine fumes. Iodine fuming
methods failed to produce any spot for samples 3 and 4.
Solvent system D failed to produce any spot under strong
day light and UV light. However, one spot at hRf 47 for sam-
ple 1, one spot at hRf 78 for sample 4, one spot at hRf 79 for
sample 5, one spot at hRf 77 for sample 6, two spots at hRf 47
and 76 for sample 7, one spot at hRf 77 for sample 9, one spot
at 76 for sample 10, one spot at hRf 77 for sample 11 of brown
color were observed on treatment with iodine fumes (Table 4).
No spot was observed for samples 2, 3 and 8 even after treat-
ment with iodine fumes.
With solvent system F, no spot was observed under strong
day light and under UV light. But with iodine fumes, one spot
at hRf 82 for sample 1, one spot at hRf 37 for sample 3, one
spot at hRf 38 for sample 5, one spot at hRf 38 for sample
6, two spots at hRf 37 and 83 for sample 7, one spot at hRf
38 for sample 8, one spot at hRf 38 for sample 9, one spot
at hRf 39 for sample 10 and one spot at hRf 39 for sample
11 were recorded (Table 4). No spots were observed for sam-
ples 2 and 4.
With solvent system G, no spot was observed under strong
day light and under UV light. But with iodine fumes, one spot
at hRf 25 for sample 1, one spot at hRf 89 for sample 4, one
spot at hRf 88 for sample 5, one spot at hRf 89 for sample
6, two spots at hRf 24 and 89 for sample 7, one spot at hRf
88 for sample 8, one spot at hRf 87 for sample 9, one spotysis of some common over the counter (OTC) cough–cold preparations, Egypt J
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Figure 1 Thin layer chromatographic plate of selected sample of OTC cough–cold preparations (tablets and standards) using solvent
system A (methanol:strong ammonia 100:1.5 v/v) after treating with iodine fuming (sample no. 1–11).
6 M.K. Chahal et al.at hRf 88 for sample 10 and one spot at hRf 87 for sample 11
were recorded (Table 4). No spots were observed for samples 2
and 3.
No spot was observed under strong day light and UV light
with solvent system I. However, one spot at hRf 82 for sample
1, one spot at hRf 83 for sample 2, one spot at hRf 84 for sam-
ple 3, one spot at hRf 85 for sample 4, one spot at hRf 85 for
sample 5, one spot at hRf 85 for sample 6, one spot at hRf 86
for sample 7, one spot at hRf 87 for sample 8, one spot at hRf
89 for sample 9, one spot of hRf 89 for sample 10 and one spot
at hRf 89 for sample 11 of brown color were observed on treat-
ment with iodine fumes (Table 4).
No spot was observed under strong day light and UV light
with solvent system K. However, one spot at hRf 35 for sample
1, one spot at hRf 35 for sample 2, one spot at hRf 82 for sam-
ple 3, one spot at hRf 65 for sample 4, one spot at hRf 82 for
sample 5, one spot at hRf 82 for sample 6, one spot at hRf 83
for sample 7, one spot at hRf 80 for sample 8, one spot at hRf
82 for sample 9, one spot of hRf 81 for sample 10 and one spot
at hRf 82 for sample 11 of brown color were observed on treat-
ment with iodine fumes (Table 4).
No spot was observed under strong day light and UV light
with solvent system M. However, one spot at hRf 53 for sam-
ple 1, one spot at hRf 67 for sample 2, one spot at hRf 67 for
sample 3, one spot at hRf 67 for sample 5, one spot at hRf 68
for sample 6, two spots at hRf 67 and 54 for sample 7, one spot
at hRf 69 for sample 8, one spot at hRf 69 for sample 9, one
spot at hRf 68 for sample 10 and one spot at hRf 68 for sample
11 of brown color were observed on treatment with iodine
fumes (Table 4). No spot was observed with sample 4 even
after treatment with iodine fumes.Please cite this article in press as: Chahal MK et al. Thin layer chromatographic anal
Forensic Sci (2016), http://dx.doi.org/10.1016/j.ejfs.2016.04.006With solvent system O, no spot was observed under strong
day light and under UV light. But with iodine fumes, one spot
at hRf 27 for sample 1, one spot at hRf 27 for sample 2, one
spot at hRf 27 for sample 3, one spot at hRf 27 for sample
4, one spot at hRf 28 for sample 5, one spot at hRf 27 for sam-
ple 6, one spots at hRf 27 for sample 7, one spot at hRf 27 for
sample 8, one spot at hRf 28 for sample 9, one spot at hRf 27
for sample 10 and one spot at hRf 27 for sample 11 of brown
color were observed (Table 4). Solvent system P failed to pro-
duce any spot under strong day light and UV light. However,
one spot at hRf 53 for sample 1, one spot at hRf 52 for sample
2, one spot at hRf 23 for sample 3, one spot at hRf 23 for sam-
ple 5, one spot at hRf 23 for sample 6, one spot at hRf 50 for
sample 7, one spot at hRf 23 for sample 8, one spot at hRf 23
for sample 9, one spot at hRf 25 for sample 10 and one spot at
hRf 24 for sample 11 of brown color were observed on treat-
ment with iodine fumes (Table 4). No spot was observed with
sample 4 even after treatment with iodine fumes.
Solvent system Q failed to produce any spot under strong
day light and UV light. However, one spot at hRf 45 for sam-
ple 1, one spot at hRf 84 for sample 2, one spot at hRf 80 for
sample 3, one spot at hRf 81 for sample 5, one spot at hRf 82
for sample 6, one spot at hRf 81 for sample 7, two spots at hRf
78 and 87 for sample 8, one spot at hRf 92 for sample 9, two
spots at hRf 72 and 92 for sample 10 and two spots at hRf 77
and 92 for sample 11 of brown color were observed on treat-
ment with iodine fumes (Table 4). No spot was observed with
sample 4 even after treatment with iodine fumes.
With solvent system S, no spot was observed under strong
day light and under UV light. But with iodine fumes, one spot
at hRf 82 for sample 1, one spot at hRf 44 for sample 2, oneysis of some common over the counter (OTC) cough–cold preparations, Egypt J






Pharmaceutical preparations tablets (hRf) Pharmaceutical preparations Cough syrups
(hRf)
S1 S2 S3 S4 FCD NIM CON SZT FRX COL COL-W CHF PTNCS PTN COF
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
A 85 30 - 66 32 67 65 35 67 35 33 35 34 34 34
85 67 67 67 82 84 8165
B 25 47 79 - 48 79 24 48 78 47 49 29 26 42 25
79 79 78 78 78 45 45 45
78
C 98 38 - - 38 39 38 38 38 37 36 - - - -
98
D 47 - - 78 79 77 47 - 77 76 77 - - - -
76
E - - - - - - - - - - - - - - -
F 82 - 37 - 38 38 37 38 38 39 39 - - - -
83
G 25 - - 89 88 89 24 88 87 88 87 - - - -
89
H - - - - - - - - - - - - - - -
I 82 83 84 85 85 85 86 87 89 89 89 - - - -
J - - - - - - - - - - - - - - -
K 35 35 82 65 82 82 83 80 82 81 82 - - - -
L 83 31 - - - - 82 - - - - - - - -
M 53 67 67 - 67 68 67 69 69 68 68 - - - -
54
N 64 - - 41 - – 64 - - - - 64 - - -
O 27 27 27 27 28 27 27 27 28 27 27 - - - -
P 53 52 23 - 23 23 50 23 23 25 24 - - - -
Q 45 84 80 - 81 82 81 78 92 72 77 - - - -
87 92 92
R 55 - - - - – 55 - - - - - - - -
S 82 44 42 - 44 45 43 44 44 44 45 - - - -
T - - - - - - - - - - - - - - -
(-) Not detected.
Thin layer chromatographic analysis of cough–cold preparations 7spot at hRf 42 for sample 3, one spot at hRf 44 for
sample 5, one spot at hRf 45 for sample 6, one spots at hRf
43 for sample 7, one spot at hRf 44 for sample 8, one spot
at hRf 44 for sample 9, one spot at hRf 44 for sample 10
and one spot at hRf 45 for sample 11 were observed (Table 4).
No spot was observed with sample 4 even after treatment with
iodine fumes.
Solvent system B (Fig. 2 and Table 4), failed to give any
spot under strong day light and UV light examination of devel-
oped thin layer chromatographic plate. However, one spot at
hRf 25 for sample 1, one spot at hRf 47 for sample 2, one spot
at hRf 79 for sample 3, two spots at hRf 48 and 79 for sample
5, one spot at hRf 79 for sample 6, two spots at hRf 24 and 79
for sample 7, two spots at hRf 48 and 78 for sample 8, one spot
at hRf 78 for sample 9, two spots at hRf 47 and 78 for sample
10 and two spots at hRf 49 and 78 for sample 11 of brown
color were observed on treatment with iodine fumes. No spot
was observed with sample 4 even after treatment with iodine
fumes. Solvent system B, comprising chloroform:methanol in
the ratio of 90:10 (v/v), was found to be the most suitable sol-
vent system for thin layer chromatographic analysis of the
studied OTC cough–cold preparations as it gave best results
in terms of their separation and differentiation.Please cite this article in press as: Chahal MK et al. Thin layer chromatographic anal
Forensic Sci (2016), http://dx.doi.org/10.1016/j.ejfs.2016.04.0063.2. For syrups
Except, solvent systems A and B, all other solvent systems,
namely C–T, did not separate the active components of the
selected OTC cough–cold preparations samples.
Solvent system A (Fig. 3 and Table 4), failed to produce
any spot under strong day light and UV light. However, one
spot at hRf 85 for sample 1, one spot at hRf 30 for sample
2, one spot at hRf 66 for sample 4, two spots at hRf 35 and
82 for sample 12, two spots at hRf 34 and 84 for sample 13,
one spot at hRf 34 for sample 14, two spots at hRf 34 and
81 for sample 15 of brown color were observed on treatment
with iodine fumes. No spot was observed with sample 3 even
after treatment with iodine fumes.
Solvent system B (Fig. 4 and Table 4), failed to give any
spot under strong day light and UV light examination of devel-
oped thin layer chromatographic plate. However, one spot at
hRf 25 for sample 1, one spot at hRf 47 for sample 2, one spot
at hRf 79 for sample 3, two spots at hRf 29 and 45 for sample
12, two spots at hRf 26 and 45 for sample 13, one spot at hRf
42 for sample 14, three spots at hRf 25, 45 and 78 for sample
15 of brown color were observed on treatment with iodine
fumes.ysis of some common over the counter (OTC) cough–cold preparations, Egypt J
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Figure 2 Thin layer chromatographic plate of selected sample of OTC cough–cold preparations (tablets and standards) using solvent
system B (chloroform:methanol 90:10 v/v) after treating with iodine fuming (sample no. 1–11).
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Figure 3 Thin layer chromatographic plate of selected sample of OTC cough–cold preparations (cough syrups and standards) using
solvent system A (methanol:strong ammonia 100:1.5 v/v) after treating with iodine fuming (sample no. 1–4 and 12–15).
8 M.K. Chahal et al.DiGregorio et al.18 analyzed dextromethorphan hydrobro-
mide using TLC and observed that a solvent system compris-
ing of ethyl acetate, methanol and concentrated ammonia in
the ratio of 85:5:10 (v/v/v) is a suitable mobile phase to sepa-
rate different components. The hRf value for dextromethor-
phan hydrobromide was 55 when examined under short UVPlease cite this article in press as: Chahal MK et al. Thin layer chromatographic anal
Forensic Sci (2016), http://dx.doi.org/10.1016/j.ejfs.2016.04.006radiation. Kim et al.38 separated dextromethorphan hydrobro-
mide and its main metabolite dextorphan using TLC and
found methylene chloride:ethanol (9:1 v/v), as an appropriate
mobile phase for their separation. Dragendorff’s reagent was
used to observe the separated components. Sagathiya et al.20
found toluene:methanol:chloroform:glacial acetic acidysis of some common over the counter (OTC) cough–cold preparations, Egypt J
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Figure 4 Thin layer chromatographic plate of selected sample of OTC cough–cold preparations (cough syrups and standards) using
solvent system B (chloroform:methanol 90:10 v/v) after treating with iodine fuming (sample no. 1–4 and 12–15).
Thin layer chromatographic analysis of cough–cold preparations 9(65:1.5:1.5:0.5 v/v/v/v) as the best solvent for the separation of
ambroxol hydrochloride, dextromethorphan hydrobromide
and guaifenesin in pharmaceutical preparations. Roy et al.19
found methanol:ethyl acetate:concentrated ammonium
hydroxide (2:17:1 v/v/v) as an appropriate solvent system for
the separation of marketed paracetamol tablet. Darwish et al.21
observed that chlorpheniramine maleate can be separated in
different pharmaceutical preparations using a solvent system
that comprises of chloroform and methanol in the ratio of
97:3 (v/v).
In the present study, chloroform: methanol (90:10 v/v) has
been found to be the best solvent system to separate the com-
pounds in OTC cough–cold preparations. Non-destructive
method of visualization by iodine fuming was found to be suit-
able for the subsequent instrumental analysis of the eluted
active components, if required. Each sample of OTC cough–
cold preparations showed a different number of spots. The
results so generated in the form of hRf value were matched
with the hRf value of the standard. The evaluation of the
TLC results was found to be good for the separation of active
ingredients in OTC cough–cold preparations. So, TLC can be
used as a screening technique at the initial stage of analysis
process.
4. Conclusion
The complexity of OTC drug preparations makes the identiﬁ-
cation of their active components extremely difﬁcult. Thin
layer chromatographic technique is rapid inexpensive method
for the separation of active components in complex
OTC cough–cold preparations. Solvent system comprises of
chloroform:methanol (90:10 v/v) has been found to be the bestPlease cite this article in press as: Chahal MK et al. Thin layer chromatographic anal
Forensic Sci (2016), http://dx.doi.org/10.1016/j.ejfs.2016.04.006solvent system to separate the different components of OTC
cough–cold preparations. The universal and non-destructive
method of visualization using iodine fuming was found to be
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